Litcius/Paper detail

A double-blind, randomized, placebo-controlled trial of SPI-62 safety and efficacy for the treatment of Cushings syndrome

Maria Fleseriu, Irina Bancos, David H. Katz

2021Endocrine Abstracts10 citationsDOI

Abstract

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Topics & Concepts

PlaceboDouble blindKey (lock)MedicineRandomized controlled trialInternal medicineAlternative medicineComputer sciencePathologyComputer securityPituitary Gland Disorders and TreatmentsAdrenal Hormones and DisordersMyasthenia Gravis and Thymoma
A double-blind, randomized, placebo-controlled trial of SPI-62 safety and efficacy for the treatment of Cushings syndrome | Litcius